project id: TCGA-UCEC; case submitter id: TCGA-BS-A0U9; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.6; spectrophotometer method: UV Spec; age at index: 59; days to birth: -21580; ethnicity: not hispanic or latino; gender: female; race: native hawaiian or other pacific islander; vital status: Alive; year of birth: 1947; age at diagnosis: 21580; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2825.0; figo stage: Stage IIA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 430.0; portion submitter id: TCGA-BS-A0U9-01B-21; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;